SOURCE-LINKED INTELLIGENCE

MERGING SUSTAINABLE AND DIGITAL CHEMICAL TECHNOLOGIES FOR THE DEVELOPMENT OF GREENER-BY-DESIGN PHARMACEUTICALS

CORDIS · observation · Publication date unknown

t advances in biomass conversion for drug synthesis; - new developments in heterogeneous catalysis; - cutting-edge flow chemistry technologies (including synthesis and purification); - automation and machine learning. To address the challenge of green and digital transition and proper supply of health technologies and products, SUSPHARMA will focus on research and innovation activities that aim at integrating five breakthrough concepts: CAT-to-PHARMA, WASTE-to-PHARMA, FLOW-to-PHARMA, PUR-to-PHARMA, and DIGITAL to PHARMA. This will deliver results that are directed to pharmaceutical industries, researchers, and innovators, prompting them to develop and produce greener pharmaceuticals that are either greener by design, intrinsically less harmful for the environment, or use greener and economically more sustainable manufacturing processes and technologies. Flow Chemistry, Synthetic Chemistry, Pharmaceutical Synthesis, Green Chemistry, Heterogeneous Catalysis, Crystallization, Chromatography, Biomass Conversion, Process Intensification, Process Chemistry

Read original source ↗ Open in workspace

recordType

award

status

SIGNED

region

EU

value

6205434.5

unit

EUR